Oxford Immunotec (OXFD) Misses Q2 EPS by 42c

Oxford Immunotec (NASDAQ: OXFD) reported Q2 EPS of ($0.74), $0.42 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $29.5 million versus the consensus estimate of $25.05 million.

GUIDANCE:

Oxford Immunotec sees Q3 2017 revenue of $29.5-30.5 million.

Oxford Immunotec sees FY 2017 revenue of $103-106 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• SanDisk upgraded at JPMorgan after investor day; shares climb